These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34339721)

  • 1. The role of topical N-acetylcysteine in ocular therapeutics.
    Eghtedari Y; Oh LJ; Girolamo ND; Watson SL
    Surv Ophthalmol; 2022; 67(2):608-622. PubMed ID: 34339721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
    Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
    Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.
    Li X; Kang B; Woo IH; Eom Y; Lee HK; Kim HM; Song JS
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3104-3114. PubMed ID: 30025127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
    Schmidl D; Werkmeister R; Kaya S; Unterhuber A; Witkowska KJ; Baumgartner R; Höller S; O'Rourke M; Peterson W; Wolter A; Prinz M; Schmetterer L; Garhöfer G
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):375-382. PubMed ID: 28441068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
    Liu D; Li J; Cheng B; Wu Q; Pan H
    Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
    Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
    Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
    Zhu L; Zhang C; Chuck RS
    Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Insulin for Ocular Surface Disease.
    Cid-Bertomeu P; Vilaltella M; Martínez M; Mir M; Huerva V
    J Ocul Pharmacol Ther; 2024 May; 40(4):204-214. PubMed ID: 38527183
    [No Abstract]   [Full Text] [Related]  

  • 10. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.
    Babizhayev MA; Burke L; Micans P; Richer SP
    Clin Interv Aging; 2009; 4():31-50. PubMed ID: 19503764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical N-acetylcysteine in the treatment of meibomian gland dysfunction.
    Akyol-Salman I; Azizi S; Mumcu U; Baykal O
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):329-33. PubMed ID: 20653477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries.
    Cruz-Cazarim ELC; Cazarim MS; Ogunjimi AT; Petrilli R; Rocha EM; Lopez RFV
    Eur J Pharm Biopharm; 2019 Jul; 140():1-10. PubMed ID: 31015020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of Corneal Staining after Cataract Surgery with and without Chitosan-N-Acetylcysteine Eye Drops.
    Palkovits S; Schlatter A; Ruiss M; Georgiev S; Zeilinger J; Pilwachs C; Findl O
    Ophthalmic Res; 2023; 66(1):1293-1299. PubMed ID: 37797590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of topical N-acetyl-cysteine and a topical steroid-antibiotic combination therapy in the treatment of meibomian gland dysfunction.
    Akyol-Salman I; Azizi S; Mumcu UY; Ateş O; Baykal O
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):49-52. PubMed ID: 21751879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
    Pinto-Fraga J; López-Miguel A; González-García MJ; Fernández I; López-de-la-Rosa A; Enríquez-de-Salamanca A; Stern ME; Calonge M
    Ophthalmology; 2016 Jan; 123(1):141-53. PubMed ID: 26520171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse dry eye model induced by topical administration of the air pollutant particulate matter 10.
    Li J; Tan G; Ding X; Wang Y; Wu A; Yang Q; Ye L; Shao Y
    Biomed Pharmacother; 2017 Dec; 96():524-534. PubMed ID: 29032336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical N-acetylcysteine accelerates wound healing in vitro and in vivo via the PKC/Stat3 pathway.
    Tsai ML; Huang HP; Hsu JD; Lai YR; Hsiao YP; Lu FJ; Chang HR
    Int J Mol Sci; 2014 May; 15(5):7563-78. PubMed ID: 24798751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of topical N-acetylcysteine in the prevention of postoperative pericardial adhesion formation in a rabbit model.
    Colak N; Nazli Y; Alpay MF; Aksoy ON; Akkaya IO; Bayrak R; Cakir O
    Cardiovasc Pathol; 2013; 22(5):368-72. PubMed ID: 23490044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.